Drug-resistant human breast cancer cells express high levels of Stat-3 signalling mediators essential for enrichment of cancer stem cells. Alone or in combination with simvastatin , low doses of gamma-tocotrienol eliminates human breast cancer stem cells via inhibition of the mevalonate pathway and activation of the novo ceramide synthesis pathways.
